Intravenous recombinant tissue plasminogen activator therapy for stroke patients receiving maintenance hemodialysis: The Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry

European Neurology

Volumn 66, Issue 1, 2011, Pages 37-41

  Naganuma, Masaki ^a   Mori, Mayumi ^a,b   Nezu, Tomohisa ^a   Makihara, Noriko ^b   Koga, Masatoshi ^a   Okada, Yasushi ^b   Minematsu, Kazuo ^a   Toyoda, Kazunori ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

Author keywords

Acute ischemic stroke; Cerebral infarction; Chronic kidney disease; End stage renal disease; Hemodialysis; Renal dysfunction; rt PA; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTIHYPERTENSIVE AGENT; HEPARIN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CAROTID ARTERY; CASE REPORT; CLINICAL EFFECTIVENESS; CORONA RADIATA (BRAIN); DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; FEMALE; FRONTAL CORTEX; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; INSULA; KIDNEY DISEASE; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREMEDICATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STROKE; TREATMENT DURATION; VOMITING;

AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; JAPAN; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79959537790     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000328792     Document Type: Article

References (13)

1. Iseki K, Fukiyama K, Okinawa Dialysis Study Group: Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. Nephrol Dial Transplant 2000; 15: 1808-1813.
2. Toyoda K, Fujii K, Fujimi S, Kumai Y, Tsuchimochi H, Ibayashi S, Iida M: Stroke in patients on maintenance hemodialysis: A 22-year single-center study. Am J Kidney Dis. 2005; 45: 1058-1066. (Pubitemid 40806519)
3. Lyrer PA, Fluri F, Gisler D, Papa S, Hatz F, Engelter ST: Renal function and outcome among stroke patients treated with IV thrombolysis. Neurology 2008; 71: 1548-1550.
4. Naganuma M, Koga M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K, Toyoda K: Reduced estimated glomerular filtration rate is associated with stroke outcomes after intravenous rt-PA: The Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA Registry. Cerebrovasc Dis 2011; 31: 123-129.
5. Toyoda K, Koga M, Naganuma M, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Minematsu K; Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement Study Investigators: Routine use of intravenous low-dose recombinant tissue plasminogen activator in Japanese patients: General outcomes and prognostic factors from the SAMURAI register. Stroke 2009; 40: 3591-3595.
6. Nezu T, Koga M, Kimura K, Shiokawa Y, Nakagawara J, Furui E, Yamagami H, Okada Y, Hasegawa Y, Kario K, Okuda S, Nishiyama K, Naganuma M, Minematsu K, Toyoda K: Pre-treatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA Registry. Neurology 2010; 75: 555-561.
7. Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Dávalos A, Erilä T, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Köhrmann M, Larrue V, Lees KR, Machnig T, Roine RO, Toni D, Vanhooren G; Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy Investigators: Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008; 39: 3316-3322.
8. Aggarwal A, Kabbani SS, Rimmer JM, Gennari FJ, Taatjes DJ, Sobel BE, Schneider DJ: Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: A potential contributor to cardiovascular risk. Am J Kidney Dis 2002; 40: 315-322. (Pubitemid 34827649)
9. Horl MP, Horl WH: Hemodialysis-associated hypertension: Pathophysiology and therapy. Am J Kidney Dis 2002; 39: 227-244. (Pubitemid 34174245)
10. Rodriguez-Yanez M, Castellanos M, Blanco M, Millan M, Nombela F, Sobrino T, Lizasoain I, Leira R, Serena J, Davalos A, Castillo J: Micro-and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke. Neurology 2006; 67: 1172-1177. (Pubitemid 44563823)
11. Yokoyama S, Hirano H, Uomizu K, Kajiya Y, Tajitsu K, Kusumoto K: High incidence of microbleeds in hemodialysis patients detected by T 2 * -weighted gradient-echo magnetic resonance imaging. Neurol Med Chir 2005; 45: 556-560. (Pubitemid 41729066)
12. Watanabe A: Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis. J Stroke Cerebrovasc Dis 2007; 16: 30-33. (Pubitemid 46073789)
13. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., Roccella EJ: National Heart, Lung, Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003; 289: 2560-2572. (Pubitemid 37430158)